The customary treatment of Type 2 diabetes is not very scientific. The root-cause of Type 2 diabetes is insulin resistance. Doesn’t it make sense to treat insulin resistance in order to control Type 2 diabetes? low sugar

Why the Customary Treatment of Type 2 Diabetes is Unscientific?

The customary medicine is well aware of insulin resistance as the root-cause of Type 2 diabetes. But when it comes to treatment, it conveniently ignores the root-cause. Instead, it focuses on controlling blood sugars by any drugs, without paying any attention to insulin resistance. Why? Because most anti-diabetic drugs do not treat insulin resistance. The anti-diabetic drug industry is huge, and has a lot of muscle. In addition, there is the powerful medical insurance industry.

In my opinion, the pharmaceutical and the medical insurance industries influence, directly or indirectly, the so called guidelines of the major medical organizations in the U.S.A. These guidelines tell physicians how to prescribe these anti-diabetic medications for their patients. Why do physicians follow these guidelines? Because physicians in the U.S.A. are fearful of medical lawsuits. There is a common belief among physicians that their best defense against any successful medical litigation is to adhere to the guidelines from big medical organizations. Perhaps now you understand why customary medicine does not focus on treating insulin resistance in the treatment of Type 2 diabetes.

What happens if you do not treat insulin resistance, but try to control blood sugar by whatever anti-diabetic medication has been recommended by big medical organizations? You suffer from the consequences of untreated insulin resistance. These consequences include coronary artery disease, stroke, poor circulation in legs, dementia, cancer growth, kidney disease, peripheral neuropathy and eye disease.

In addition, your insulin resistance gets worse if it stays untreated. Then, you have to keep adding more and more drugs to even control the blood sugars. This is what is called the “step-up” approach. You keep adding more and more steps (drugs) with the passage of time to control your blood sugars. Eventually, most diabetics end up on insulin, and consequently develop many of the complications of insulin resistance and diabetes.

My Scientific Approach to the Treatment of Type 2 Diabetes

Fifteen years ago, I got the courage to be free of the prison of these medical guidelines. Instead, I focused on treating Type 2 diabetes at its root – insulin resistance. Only then, was I able to not only treat blood sugars effectively, but also to prevent other complications of insulin resistance and diabetes. I call it my scientific approach to treat Type 2 diabetes.

With my approach, once insulin resistance comes under control, you start to reduce the number of medications, even coming off insulin. That’s why I like to call this approach the “step-down.” You come down (or reduce) the steps (drugs) with the passage of time, instead off adding steps (drugs).

Over the last fifteen years, I have seen some excellent results in my diabetic patients. My new treatment plan, outlined in this book, not only controls diabetes, but also reduces serum triglycerides, increases HDL (good) cholesterol, changes LDL cholesterol from Type B (more dangerous) to Type A (less dangerous), and re-establishes the body’s ability to break clots. It accomplishes these major goals by effectively treating insulin resistance—the root cause of these medical disorders. In this way, my new treatment strategy significantly reduces the risk for heart attack, stroke, leg amputation, dementia, kidney disease, eye disease, and other complications of diabetes. Those who already have gone through a coronary angioplasty can stop the vicious cycle of repeated angioplasties. Those who have suffered a stroke can prevent future episodes. Those with memory loss and dementia can prevent further deterioration. Those who have developed an early stage of kidney disease can prevent further progression and avoid ending up on kidney dialysis. Patients with diabetes can now prevent leg amputation and blindness. This certainly has been my clinical experience as the director of the Jamila Diabetes & Endocrine Medical Center.

By using this new treatment strategy, the vast majority of my Type 2 diabetic patients do not need to resort to insulin shots to control their diabetes. Most patients who are already on insulin injections gradually come off insulin. The vast majority of my diabetic patients have not required coronary angioplasties, heart bypass surgery, or kidney dialysis. Patients with previous strokes have not suffered any further episodes. There have been no leg amputations or loss of eyesight in many years.